Recombinant live fowlpox virus vectors and their use in pharmaceutical compositions against hepatitis C virus

摘要

Recombinant fowl pox virus expressing hepatitis C virus proteins and their use in pharmaceuticals compositions, able to induce a cellular immune response against the hepatitis C virus, alter administration of a reduced number of doses. The pharmaceutical compositions of this invention are useful for prevention and treatment of infections associated with the hepatitis C virus.